Article Information
History
- May 20, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Luc Bergougnan1,
- Grit Andersen2,
- Leona Plum-Mörschel3,
- Maria Francesca Evaristi1,
- Bruno Poirier1,
- Agnes Tardat4,
- Marcel Ermer3,
- Theresa Herbrand2,
- Jorge Arrubla2,
- Hans Veit Coester2,
- Roberto Sansone5,
- Christian Heiss6,
- Olivier Vitse4,
- Fabrice Hurbin4,
- Rania Boiron1,
- Xavier Benain4,
- David Radzik1,
- Philip Janiak1,
- Anthony J Muslin7,
- Lionel Hovsepian1,
- Stephane Kirkesseli1,
- Paul Deutsch8 and
- Ashfaq A Parkar8,*
- 1Sanofi R&D, 1 Avenue Pierre Brossolette, 91385 Chilly Mazarin, France
- 2Profil Institut für Stoffwechselforschung GmbH, Hellersbergstraße 9, 41460 Neuss, Germany
- 3Profil Mainz GmbH & Co. KG, Malakoff-Passage, Rheinstraße 4C, Eingang via Templerstraße, D-55116 Mainz, Germany
- 4Sanofi R&D, 371 Rue du Professeur Blayac, 34080 Montpellier, France
- 5University Hospital Düsseldorf, Division of Cardiology, Pulmonary diseases and Vascular medicine, 40225 Düsseldorf, Germany
- 6Department of Clinical and Experimental Medicine, University of Surrey, Stag Hill, Guildford GU2 7XH, UK
- 7Sanofi US Services, 640 Memorial Drive, Cambridge MA 02139, USA
- 8Sanofi US Services, 55 Corporate Drive, Bridgewater, NJ 08807, USA
- ↵*Correspondence
: Ashfaq A Parkar, Global Project Head, Cardiovascular and Diabetes, 55 Corporate Drive, Bridgewater, NJ 08807 USA. E-mail: ashfaqaparkar{at}gmail.com.